Company intelligence
Fraunhofer ITEM
PIONEERS FOR SUSTAINABLE HEALTH
About Fraunhofer ITEM
The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of more than 70 institutes of the Fraunhofer-Gesellschaft, the world’s leading applied research organization. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on respiratory research, the R&D portfolio at our Hannover headquarters comprises three business areas: Drug Development, Chemical Safety and Translational Biomedical Engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.
Verified activity
Signals from Fraunhofer ITEM
5 published signals
Research & Knowledge
Fraunhofer ITEM published a research article titled Region-specific immune regulation determines differential response to JAK1 inhibition in Crohn’s disease ex vivo in the Journal of Crohn's and Colitis.
Reported by Fraunhofer ITEM
Presence & Recognition
Fraunhofer ITEM's Business Development Manager Patricia Mattis presented at the Medizintechnik 2026 conference in Frankfurt on the topic of CE compliance and reimbursement.
Reported by Fraunhofer ITEM
Research & Knowledge
Fraunhofer ITEM researchers played a key role in developing the ASPA workflow within the EU-funded RISK-HUNT3R project.
Reported by Fraunhofer ITEM
Research & Knowledge
Fraunhofer ITEM is developing physiologically based kinetic models to calculate how inhaled substances are absorbed, distributed, metabolized, and excreted by the human body.
Reported by Fraunhofer ITEM
People
Fraunhofer ITEM welcomed Dr. Annette Bitsch as Institute Director on September 1, following the retirement of Prof. Dr. Norbert Krug.
Reported by Fraunhofer ITEM